Press release
Rising Obesity Rates Fueling Surge in the Weight Loss Drugs Market: A Key Factor Shaping the Future of the Weight Loss Drugs Market in 2025
What Are the Projections for the Size and Growth Rate of the Weight Loss Drugs Market?
The market size for weight loss medications has seen significant expansion in the past few years. It is projected to increase from $2.87 billion in 2024 to $4.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 47.6%. Factors contributing to the exceptional growth during the historic phase include soaring obesity figures, alterations in lifestyles, better awareness and understanding, timely diagnoses of health issues, and increased spending on healthcare.
The market size for weight loss medications is anticipated to experience significant expansion in the forthcoming years. It is projected to achieve a value of $17.08 billion in 2029, with a compound annual growth rate (CAGR) of 41.7%. Factors contributing to the growth during the forecast period encompass an aging population, influence of social media, trends in fitness and wellness, cultural beauty standards, and investment in the pharmaceutical industry. Key trends predicted during this period involve technological breakthroughs, emphasis on solutions not requiring prescriptions, tailored medicine, combination therapies, product development and subsequent market monitoring.
What Are the Main Catalysts for Growth in the Weight Loss Drugs Market?
The escalation in obesity rates is predicted to fuel the expansion of the market for weight loss drugs. The obesity rate alludes to the percentage of individuals in a community whose body mass index (BMI) is 30 or more. Weight loss drugs, which are employed in obesity treatment, aid subjects in shedding weight by diminishing hunger, amplifying sensations of satiety, or obstructing nutrient absorption. For instance, the Centers for Disease Control and Prevention, a US-based governmental body, reported in September 2023 that the rates of adult obesity surpassed 35% in 19 states in 2021 and 22 states in 2022. Moreover, the prevalence of adult obesity was 35% or more in 2022. In addition, the World Obesity Federation, a UK-based non-profit organization, projected in March 2023 that over 4 billion people will likely be obese by 2035. Thus, the surge in obesity rates is propelling the increase in the weight loss drugs market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13761&type=smp
Which Businesses Are at the Forefront of Weight Loss Drugs Market Development?
Major companies operating in the weight loss drugs market report are Pfizer Inc., Roche, Merck & Co., AbbVie Inc., Novartis AG, Bristol Myers Squibb, Sanofi S.A., AstraZeneca PLC, LG Chem, GlaxoSmithKline, Takeda Pharmaceutical Company, Eli Lilly and Company, Bayer AG, Amgen Inc., Boehringer Ingelheim group, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical, Taj Pharmaceuticals Ltd., Zhongshan Pharmaceutical Co. Ltd., Dm Pharma, Lunan Pharmaceutical Group Corporation, Wolfson Berg Ltd., Swiss Research Labs Ltd.
What Are the Latest Innovations in the Weight Loss Drugs Market?
Key players in the weight loss medication market are focusing on creating novel drugs such as Zepbound (tirzepatide) injection, to better cater to patients' needs. Zepbound is an injectable drug, taken once weekly, that acts as a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). In November 2023, the American-based pharmaceutical company, Eli Lilly and Company, secured FDA approval for the tirzepatide injection (Zepbound) for consistent weight management in adults suffering from overweight or obesity and at least 1 weight-related condition. Zepbound has a strong potential for commercial success, being the first and only FDA-approved treatment for obesity that activates both GIP and GLP-1 receptors.
How Is the Weight Loss Drugs Market Segmented?
The weight loss drugs market covered in this report is segmented -
1) By Type: Liquid, Tablets, Capsules
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Weight-Reducing Aid, Fat Absorption Inhibitors, Metabolic Boosters
Subsegments:
1) By Liquid: Syrups, Solutions, Suspensions
2) By Tablets: Immediate-Release Tablets, Extended-Release Tablets
3) By Capsules: Hard Capsules, Softgel Capsules
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report
Where Is the Weight Loss Drugs Market Growth Most Prominent?
North America was the largest region in the Weight Loss Drugs market in 2024. The regions covered in the weight loss drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Weight Loss Drugs Global Market Report?
- Market Size Analysis: Analyze the Weight Loss Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Weight Loss Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Weight Loss Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Weight Loss Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13761
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
The market size for weight loss medications has seen significant expansion in the past few years. It is projected to increase from $2.87 billion in 2024 to $4.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 47.6%. Factors contributing to the exceptional growth during the historic phase include soaring obesity figures, alterations in lifestyles, better awareness and understanding, timely diagnoses of health issues, and increased spending on healthcare.
The market size for weight loss medications is anticipated to experience significant expansion in the forthcoming years. It is projected to achieve a value of $17.08 billion in 2029, with a compound annual growth rate (CAGR) of 41.7%. Factors contributing to the growth during the forecast period encompass an aging population, influence of social media, trends in fitness and wellness, cultural beauty standards, and investment in the pharmaceutical industry. Key trends predicted during this period involve technological breakthroughs, emphasis on solutions not requiring prescriptions, tailored medicine, combination therapies, product development and subsequent market monitoring.
What Are the Main Catalysts for Growth in the Weight Loss Drugs Market?
The escalation in obesity rates is predicted to fuel the expansion of the market for weight loss drugs. The obesity rate alludes to the percentage of individuals in a community whose body mass index (BMI) is 30 or more. Weight loss drugs, which are employed in obesity treatment, aid subjects in shedding weight by diminishing hunger, amplifying sensations of satiety, or obstructing nutrient absorption. For instance, the Centers for Disease Control and Prevention, a US-based governmental body, reported in September 2023 that the rates of adult obesity surpassed 35% in 19 states in 2021 and 22 states in 2022. Moreover, the prevalence of adult obesity was 35% or more in 2022. In addition, the World Obesity Federation, a UK-based non-profit organization, projected in March 2023 that over 4 billion people will likely be obese by 2035. Thus, the surge in obesity rates is propelling the increase in the weight loss drugs market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13761&type=smp
Which Businesses Are at the Forefront of Weight Loss Drugs Market Development?
Major companies operating in the weight loss drugs market report are Pfizer Inc., Roche, Merck & Co., AbbVie Inc., Novartis AG, Bristol Myers Squibb, Sanofi S.A., AstraZeneca PLC, LG Chem, GlaxoSmithKline, Takeda Pharmaceutical Company, Eli Lilly and Company, Bayer AG, Amgen Inc., Boehringer Ingelheim group, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical, Taj Pharmaceuticals Ltd., Zhongshan Pharmaceutical Co. Ltd., Dm Pharma, Lunan Pharmaceutical Group Corporation, Wolfson Berg Ltd., Swiss Research Labs Ltd.
What Are the Latest Innovations in the Weight Loss Drugs Market?
Key players in the weight loss medication market are focusing on creating novel drugs such as Zepbound (tirzepatide) injection, to better cater to patients' needs. Zepbound is an injectable drug, taken once weekly, that acts as a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). In November 2023, the American-based pharmaceutical company, Eli Lilly and Company, secured FDA approval for the tirzepatide injection (Zepbound) for consistent weight management in adults suffering from overweight or obesity and at least 1 weight-related condition. Zepbound has a strong potential for commercial success, being the first and only FDA-approved treatment for obesity that activates both GIP and GLP-1 receptors.
How Is the Weight Loss Drugs Market Segmented?
The weight loss drugs market covered in this report is segmented -
1) By Type: Liquid, Tablets, Capsules
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Weight-Reducing Aid, Fat Absorption Inhibitors, Metabolic Boosters
Subsegments:
1) By Liquid: Syrups, Solutions, Suspensions
2) By Tablets: Immediate-Release Tablets, Extended-Release Tablets
3) By Capsules: Hard Capsules, Softgel Capsules
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report
Where Is the Weight Loss Drugs Market Growth Most Prominent?
North America was the largest region in the Weight Loss Drugs market in 2024. The regions covered in the weight loss drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Weight Loss Drugs Global Market Report?
- Market Size Analysis: Analyze the Weight Loss Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Weight Loss Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Weight Loss Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Weight Loss Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13761
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
